Wang Mi, Chen Wen-Tao, Wang Hao-Ting, Liu Bang-Shan, Ju Yu-Meng, Dong Qiang-Li, Lu Xiao-Wen, Sun Jin-Rong, Zhang Liang, Guo Hua, Zhao Fu-Tao, Li Wei-Hui, Zhang Li, Li Ze-Xuan, Liao Mei, Zhang Yan, Liu Jin, Li Ling-Jiang
Department of Mental Health Center, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
World J Psychiatry. 2024 Oct 19;14(10):1474-1483. doi: 10.5498/wjp.v14.i10.1474.
Symptoms of depression and comorbid anxiety are known risk factors for cognitive impairment in major depressive disorder (MDD). Understanding their relationships is crucial for developing targeted interventions to mitigate cognitive impairments in MDD patients. We expect that the severity of sleep disturbances and other depressive symptoms will be positively correlated with the degree of cognitive impairments. We also hypothesize that anxiety symptoms, especially psychic anxiety, is a key factor in predicting cognitive performance in MDD patients and may indirectly contribute to cognitive impairment by affecting sleep disturbances and other potential factors.
To determine which dimension of the depressive and anxiety symptoms predicts cognitive impairment during a depressive episode.
A comprehensive neurocognitive test battery assessed executive function, attention, processing speed, and memory in 162 medication-free MDD patients and 142 matched healthy controls. The 24-item Hamilton Depression Rating Scale was used to assess depressive symptoms, and the 14-item Hamilton Anxiety Scale was used to assess anxiety symptoms. Linear regression analyses and mediation analyses were conducted to evaluate the impact of depressive and anxiety symptoms, as well as their interactions, on cognitive impairments.
Among the depressive symptoms, sleep disturbances were associated with poorer executive function ( = 0.004), lower processing speed ( = 0.047), and memory impairments ( < 0.001), and psychomotor retardation (PR) was associated with lower processing speed in patients with MDD ( = 0.019). Notably, PR was found to mediate the impact of sleep disturbances on the processing speed. Regarding anxiety symptoms, psychic anxiety, rather than somatic anxiety, was associated with cognitive impairments in all aspects. Sleep disturbances mediated the effect of psychic anxiety on executive function [β = -0.013, BC CI (-0.027, -0.001)] and memory [β = -0.149, BC CI (-0.237, -0.063)], while PR mediated its effect on processing speed (β = -0.023, BC CI (-0.045, -0.004)].
Sleep disturbances may be a key predictor of poorer executive function, lower processing speed, and memory loss, while PR is crucial for lower processing speed during a depressive episode. Psychic anxiety contributes to all aspects of cognitive impairments, mediated by sleep disturbances and PR.
抑郁症状及共病焦虑是重度抑郁症(MDD)患者认知障碍的已知风险因素。了解它们之间的关系对于制定有针对性的干预措施以减轻MDD患者的认知障碍至关重要。我们预期睡眠障碍及其他抑郁症状的严重程度将与认知障碍程度呈正相关。我们还假设焦虑症状,尤其是精神性焦虑,是预测MDD患者认知表现的关键因素,并且可能通过影响睡眠障碍及其他潜在因素间接导致认知障碍。
确定抑郁和焦虑症状的哪个维度可预测抑郁发作期间的认知障碍。
采用一套全面的神经认知测试组合评估了162名未服用药物的MDD患者及142名匹配的健康对照的执行功能、注意力、处理速度和记忆力。使用24项汉密尔顿抑郁评定量表评估抑郁症状,使用14项汉密尔顿焦虑量表评估焦虑症状。进行线性回归分析和中介分析以评估抑郁和焦虑症状及其相互作用对认知障碍的影响。
在抑郁症状中,睡眠障碍与较差的执行功能(P = 0.004)、较低的处理速度(P = 0.047)和记忆障碍(P < 0.001)相关,且精神运动迟缓(PR)与MDD患者较低的处理速度相关(P = 0.019)。值得注意的是,发现PR介导了睡眠障碍对处理速度的影响。关于焦虑症状,精神性焦虑而非躯体性焦虑与各方面的认知障碍相关。睡眠障碍介导了精神性焦虑对执行功能的影响[β = -0.013,BC CI(-0.027,-0.001)]和记忆力的影响[β = -0.149,BC CI(-0.237,-0.063)],而PR介导了其对处理速度的影响(β = -0.023,BC CI(-0.045,-0.004)]。
睡眠障碍可能是较差的执行功能、较低的处理速度和记忆力丧失的关键预测因素,而PR对于抑郁发作期间较低的处理速度至关重要。精神性焦虑通过睡眠障碍和PR介导导致认知障碍的各个方面。